triazoles has been researched along with Chronic Hepatitis C in 17 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (23.53) | 29.6817 |
2010's | 13 (76.47) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Biliotti, E; Esvan, R; Franchi, C; Palazzo, D; Serani, M; Silvestri, AM; Sorrentino, F; Spaziante, M; Taliani, G; Volpicelli, L | 1 |
Degli Antoni, A; Ferrari, C; Fragola, V; Manfredi, R; Weimer, LE | 1 |
Yanai, H | 2 |
Carlson, D; Mattioni, J; Moore, JE; Portnoy, JE; Sataloff, RT | 1 |
Angarano, G; Bruno, G; Ladisa, N; Maggi, P; Perilli, F; Santoro, C; Saracino, A; Volpe, A | 1 |
Mahmoud, A; Musallam, KM; Taher, AT | 1 |
Ferrando-Martínez, S; García-Pergañeda, A; Genebat, M; González-Serna, A; Leal, M; Méndez, G; Pulido, I; Romero-Sánchez, MC; Ruiz-Mateos, E | 1 |
Beaulieu, PL | 1 |
Craig, C; Gore, K; Hammond, J; Lewis, M; Simpson, P; Troke, PJ; Westby, M | 1 |
Camacho, A; de los Santos, I; Di Lello, F; Gómez-Mateos, J; Macías, J; Márquez, M; Mata, R; Ojeda, G; Pineda, JA; Portilla, J; Rivero, A; Sanz-Sanz, J; Viloria, MM | 1 |
Andrés, R; Elías, T; Fernandez de Orueta, L; Pintado, V | 1 |
Hayashi, H; Maeda, H; Naoe, T; Ohashi, H; Saito, H; Tomita, A | 1 |
Boesecke, C; Pett, SL | 1 |
Al-Attar, A; Redett, RJ; Williams, CG | 1 |
Herrmann, E; Hofmann, WP; Kronenberger, B; Lohmann, V; Mihm, U; Polta, A; Sarrazin, C; Schönberger, B; Sonntag, T; Zeuzem, S | 1 |
Berg, T; Bergk, A; Krüger, D; Plöckinger, U; Weich, V; Wiedenmann, B | 1 |
2 review(s) available for triazoles and Chronic Hepatitis C
Article | Year |
---|---|
Filibuvir, a non-nucleoside NS5B polymerase inhibitor for the potential oral treatment of chronic HCV infection.
Topics: Administration, Oral; Animals; Antiviral Agents; Hepacivirus; Hepatitis C, Chronic; Humans; Nucleic Acid Synthesis Inhibitors; Pyrones; RNA-Dependent RNA Polymerase; Triazoles; Viral Nonstructural Proteins | 2010 |
Clinical studies with chemokine receptor-5 (CCR5)-inhibitors.
Topics: Antibodies, Monoclonal; Antiviral Agents; CCR5 Receptor Antagonists; Coinfection; Cyclohexanes; Hepatitis C, Chronic; HIV; HIV Antibodies; HIV Infections; Humans; Maraviroc; Molecular Diagnostic Techniques; Triazoles; Viral Tropism; Virology | 2012 |
1 trial(s) available for triazoles and Chronic Hepatitis C
Article | Year |
---|---|
Characterization of resistance to the nonnucleoside NS5B inhibitor filibuvir in hepatitis C virus-infected patients.
Topics: Antiviral Agents; Base Sequence; Cell Line, Tumor; Cloning, Molecular; Drug Resistance, Viral; Hepacivirus; Hepatitis C, Chronic; Humans; Inhibitory Concentration 50; Methionine; Models, Molecular; Molecular Sequence Data; Mutagenesis, Site-Directed; Mutation; Pyrones; Replicon; RNA-Dependent RNA Polymerase; Transfection; Triazoles; Viral Nonstructural Proteins; Virus Replication | 2012 |
14 other study(ies) available for triazoles and Chronic Hepatitis C
Article | Year |
---|---|
Interferon free antiviral treatment of chronic hepatitis C in patients affected by β-thalassemia major.
Topics: Adult; Antiviral Agents; Benzimidazoles; Benzoates; beta-Thalassemia; Cryoglobulinemia; Deferasirox; Deferoxamine; Elasticity Imaging Techniques; Female; Ferritins; Fluorenes; Hepatitis C, Chronic; Humans; Iron Chelating Agents; Iron Overload; Liver Cirrhosis; Male; Quality of Life; Sofosbuvir; Triazoles; Viral Load | 2017 |
A reduced grade of liver fibro-steatosis after raltegravir, maraviroc and fosamprenavir in an HIV/HCV co-infected patient with chronic hepatitis, cardiomyopathy, intolerance to nelfinavir and a marked increase of serum creatine phosphokinase levels probab
Topics: Adult; Carbamates; Cardiomyopathies; Chemical and Drug Induced Liver Injury; Creatine Kinase; Cyclohexanes; Drug Substitution; Drug Therapy, Combination; Fatty Liver; Furans; Hepatitis C, Chronic; HIV Fusion Inhibitors; HIV Infections; HIV Integrase Inhibitors; HIV Protease Inhibitors; Humans; Liver Cirrhosis; Male; Maraviroc; Organophosphates; Pyrrolidinones; Raltegravir Potassium; Sulfonamides; Triazoles | 2012 |
Dipeptidyl peptidase-4 inhibitor sitagliptin significantly reduced hepatitis C virus replication in a diabetic patient with chronic hepatitis C virus infection.
Topics: Diabetes Complications; Diabetes Mellitus; Dipeptidyl-Peptidase IV Inhibitors; Female; Hepatitis C, Chronic; Humans; Pyrazines; Triazoles | 2014 |
Laryngotracheal mucormycosis: Report of a case.
Topics: Antifungal Agents; Burkitt Lymphoma; Debridement; Dysphonia; Echinocandins; Hepatitis C, Chronic; HIV Infections; Humans; Hyperbaric Oxygenation; Laryngitis; Laryngoscopy; Lipopeptides; Male; Micafungin; Middle Aged; Mucormycosis; Neurosyphilis; Respiratory Distress Syndrome; Respiratory Sounds; Tracheitis; Tracheotomy; Triazoles | 2016 |
Effects of Therapy with Maraviroc on the Carotid Intima Media Thickness in HIV-1/HCV Co-infected Patients.
Topics: Biomarkers; Carotid Intima-Media Thickness; CCR5 Receptor Antagonists; Coinfection; Cyclohexanes; Female; Hepacivirus; Hepatitis C, Chronic; HIV Infections; HIV-1; Humans; Liver Cirrhosis; Male; Maraviroc; Middle Aged; Pilot Projects; Polymerase Chain Reaction; Prospective Studies; Triazoles; Ultrasonography, Doppler, Color | 2017 |
Iron and hepatitis C: what can we learn from thalassemia major?
Topics: Adult; Benzoates; beta-Thalassemia; Chelation Therapy; Deferasirox; Deferoxamine; Female; Ferritins; Hepacivirus; Hepatitis C, Chronic; Humans; Iron; Iron Deficiencies; Male; Phlebotomy; Siderophores; Triazoles | 2008 |
Long-term immunovirogical effect and tolerability of a maraviroc-containing regimen in routine clinical practice.
Topics: Adult; Anti-HIV Agents; Anti-Retroviral Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Cyclohexanes; Female; Hepatitis C, Chronic; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Male; Maraviroc; Middle Aged; Pyrrolidinones; Raltegravir Potassium; Retrospective Studies; Spain; Time; Triazoles; Viral Load | 2010 |
Sitagliptin in treatment of diabetes complicated by chronic hepatitis C.
Topics: Blood Glucose; Comorbidity; Diabetes Complications; Diabetes Mellitus; Dipeptidyl-Peptidase IV Inhibitors; Female; Hepatitis C, Chronic; Humans; Middle Aged; Pyrazines; Sitagliptin Phosphate; Treatment Outcome; Triazoles | 2010 |
Lack of short-term increase in serum mediators of fibrogenesis and in non-invasive markers of liver fibrosis in HIV/hepatitis C virus-coinfected patients starting maraviroc-based antiretroviral therapy.
Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Biomarkers; Cyclohexanes; Female; Hepacivirus; Hepatitis C, Chronic; HIV Infections; Humans; Liver Cirrhosis; Male; Maraviroc; Matrix Metalloproteinase 2; Middle Aged; Pilot Projects; Prospective Studies; RNA, Viral; Serum; Tissue Inhibitor of Metalloproteinase-1; Transforming Growth Factor beta; Triazoles | 2012 |
[Vertebral aspergillosis in a cirrhotic patient: an uncommon cause of spondylitis].
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Biomarkers; Cross Infection; Fatal Outcome; Galactose; Haemophilus influenzae; Hepatitis C, Chronic; Humans; Immunocompromised Host; Liver Cirrhosis; Low Back Pain; Lumbar Vertebrae; Male; Mannans; Middle Aged; Multiple Organ Failure; Opportunistic Infections; Pulmonary Disease, Chronic Obstructive; Pyrimidines; Spondylitis; Triazoles; Voriconazole | 2012 |
Determination of ferritin and hemosiderin iron in patients with normal iron stores and iron overload by serum ferritin kinetics.
Topics: Anemia; Benzoates; Biomarkers; Computer Simulation; Deferasirox; Female; Ferritins; Hemochromatosis; Hemosiderin; Hepatitis C, Chronic; Humans; Iron; Iron Chelating Agents; Iron Overload; Japan; Kinetics; Liver; Male; Middle Aged; Models, Biological; Triazoles | 2012 |
Rare lower extremity invasive fungal infection in an immunosuppressed patient: Exserohilum longirostratum.
Topics: Aged; Antifungal Agents; Cellulitis; Comorbidity; Debridement; Disease Progression; Hepatitis C, Chronic; Humans; Immunocompromised Host; Leg Ulcer; Male; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2006 |
Mutagenic effect of ribavirin on hepatitis C nonstructural 5B quasispecies in vitro and during antiviral therapy.
Topics: Adult; Antiviral Agents; Cell Line, Tumor; DNA Mutational Analysis; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Middle Aged; Monosaccharides; Mutagens; Mutation; Replicon; Retrospective Studies; Ribavirin; RNA, Viral; Time Factors; Triazoles; Viral Nonstructural Proteins | 2007 |
Hepatitis-C patients have reduced growth hormone (GH) secretion which improves during long-term therapy with pegylated interferon-alpha.
Topics: Adult; Aged; Antiviral Agents; Drug Therapy, Combination; Female; Growth Hormone; Hepatitis C, Chronic; Humans; Insulin-Like Growth Factor Binding Protein 1; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Monosaccharides; Pituitary Function Tests; Polyethylene Glycols; Prospective Studies; Recombinant Proteins; Ribavirin; Statistics, Nonparametric; Treatment Outcome; Triazoles | 2007 |